Received Mar 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | IM |
vertigo; Dizziness; Headache; shaky legs; This non-serious case was reported by a consumer via call center representative and described the occurrence of dizziness in a 76-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. The patient's past medical history included stent placement (Coronary artery disease history of stents 2 times). Concurrent medical conditions included hypothyroidism, coronary artery disease (Coronary artery disease history of stents 2 times), hyperlipidemia, blepharitis and hypertension. Concomitant products included levothyroxine sodium (Levothyroxine), metoprolol, doxycycline, atorvastatin and hydrocortisone. On 13-MAR-2025, the patient received the 1st dose of Shingrix (intramuscular, unknown deltoid) .5 ml. On 14-MAR-2025, 1 days after receiving Shingrix, the patient experienced dizziness (Verbatim: Dizziness), headache (Verbatim: Headache) and tremor limb (Verbatim: shaky legs). On an unknown date, the patient experienced vertigo (Verbatim: vertigo). The outcome of the dizziness, headache, tremor limb and vertigo were unknown. It was unknown if the reporter considered the dizziness, headache, tremor limb and vertigo to be related to Shingrix. It was unknown if the company considered the dizziness, headache, tremor limb and vertigo to be related to Shingrix. Additional Information: GSK Receipt Date: 18-DEC-2024 The patient reported that she received her Shingrix dose number one on 13th March 2025. Beginning on 14th March 2025 she began experiencing dizziness and headache along with shaky legs. The lot number for the dose was not provided to the patient. She was referred to an urgent care facility and was diagnosed with vertigo there. The name of the treating physician was not available. The patient's own Primary care physician had just recently retired, so she had no HCP to contact at this time.
Blepharitis; Coronary artery disease (Coronary artery disease history of stents 2 times); Hyperlipidemia; Hypertension; Hypothyroidism
Medical History/Concurrent Conditions: Stent placement (Coronary artery disease history of stents 2 times)
LEVOTHYROXINE; METOPROLOL; DOXYCYCLINE; ATORVASTATIN; HYDROCORTISONE